ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
3 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
2 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stocksa
|
2.2K |
648K |
2 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
2.2K
|
648K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
8 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Oncolytic Virus Presentation at AACR 2021 Meeting
|
|
stocksa
|
12 |
6.5K |
21 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
12
|
6.5K
|
21
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
6 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
2 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
5 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
1 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stocksa
|
1.0K |
455K |
3 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
455K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
stocksa
|
102 |
28K |
1 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
102
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stocksa
|
8.9K |
3.3M |
1 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
stocksa
|
102 |
28K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
102
|
28K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
stocksa
|
102 |
28K |
6 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
102
|
28K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
stocksa
|
113 |
35K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
113
|
35K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Ltd Files For Shelf Of Up To $180 Mln ADS Representing Ordinary Shares
|
|
stocksa
|
102 |
28K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
102
|
28K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stocksa
|
1.0K |
455K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
1.0K
|
455K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stocksa
|
1.0K |
455K |
5 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
1.0K
|
455K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
165
|
30K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
stocksa
|
654 |
150K |
8 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
654
|
150K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
1 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
30K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
30K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director's Interest Notice - Appendix 3X
|
|
stocksa
|
20 |
7.1K |
1 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
20
|
7.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director's Interest Notice - Appendix 3X
|
|
stocksa
|
20 |
7.1K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
20
|
7.1K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stocksa
|
8.9K |
3.3M |
0 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
3.8K
|
951K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
0 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
30K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
3 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
30K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Poll, do we have any medical professionals.
|
|
stocksa
|
165 |
30K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
165
|
30K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
stocksa
|
171 |
43K |
3 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
171
|
43K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stocksa
|
8.9K |
3.3M |
2 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
stocksa
|
136 |
32K |
0 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
136
|
32K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
stocksa
|
136 |
32K |
4 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
136
|
32K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
stocksa
|
429 |
106K |
0 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
429
|
106K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
stocksa
|
429 |
106K |
3 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
429
|
106K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
stocksa
|
429 |
106K |
3 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
429
|
106K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stocksa
|
8.9K |
3.3M |
0 |
27/03/21 |
27/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Phase 3 Trial Results Presented at Investor Conference
|
|
stocksa
|
11 |
6.8K |
1 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
1 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
3.8K
|
951K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Bullish - Finally
|
|
stocksa
|
141 |
25K |
3 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
141
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Bullish - Finally
|
|
stocksa
|
141 |
25K |
0 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
141
|
25K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
0 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
3.8K
|
951K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
2 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
3.8K
|
951K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Phase 3 Trial Results Presented at Investor Conference
|
|
stocksa
|
11 |
6.8K |
0 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
11
|
6.8K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stocksa
|
3.8K |
951K |
3 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
3.8K
|
951K
|
3
|
|